LUMIRADX LTD

CA Healthcare Acquisition Corp. (Nasdaq: CAHC) was a healthcare-focused blank-check company that completed its initial public offering in 2020. In April 2021, CAHC announced a definitive business combination with LumiraDx Limited, a UK-based diagnostics technology company offering point-of-care testing platforms across infectious disease and chronic condition indications. The transaction subsequently closed, bringing LumiraDx to public markets through the SPAC structure and representing one of the more prominent healthcare sector de-SPAC deals of that cycle. For complete filing histories, deal timelines, and analytics on CAHC and comparable healthcare SPAC transactions, sign up for full data access at SpacDesk.

SPAC Counterparty (1)